CytoDyn CYDY
OTC CYDY
$0.21 -0.02 (-8.70%)
At close: Sep 28, 2026 · 4:00 PM EDT

CytoDyn (CYDY) EV to EBITDA (2024 - 2025)

Updated

CytoDyn's EV to EBITDA came in at 42.65 for fiscal Q4 2025 (quarter ended May 31, 2025), down 5.4% from the prior quarter.

Analysis

CytoDyn (CYDY) EV to EBITDA (2024 - 2025) Analysis & Trends

Going back to fiscal Q1 2025, CytoDyn's EV to EBITDA data covers 4 quarters.

  • The five-year range for quarterly EV to EBITDA is 13.01 (fiscal Q2 2025) to 45.08 (fiscal Q3 2025).
  • Business Quant data shows CYDY's EV to EBITDA at 45.08 (Q3 2025), 13.01 (Q2 2025) and 17.53 (Q1 2025) in the three fiscal quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 CytoDyn 288.44 Mn 288.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2025 42.65
Feb 28, 2025 45.08
Nov 30, 2024 13.01
Aug 31, 2024 17.53
API Access

CytoDyn EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CYDY&period=max&api_key=YOUR_API_KEY